1. Medication Non-adherence among Liver Transplant Recipients

   • Lauren S. Jones
   • Marina Serper

   Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 24 October 2020 Pages: 327 - 336

   

2. Role of Immunomodulators in Functional Cure Strategies for HBV

   • Benedikt Binder
   • Maike Hofmann
   • Robert Thimme

   Hepatitis B (JK Lim, Section Editor) Open access 27 August 2020 Pages: 337 - 344

   

3. Chronic Hepatitis B and HIV Coinfection: a Continuing Challenge in the Era of Antiretroviral Therapy

   • H. Nina Kim

   Hepatitis B (JK Lim, Section Editor) Open access 16 September 2020 Pages: 345 - 353

   

4. Diagnosis and Management of Occult Hepatitis B Infection

   • Brian T. Lee
   • Ponni V. Perumalswami

   Hepatitis B (JK Lim, Section Editor) 23 November 2020 Pages: 354 - 361

   

5. The Role of RNA Interference in Functional Cure Strategies for Chronic Hepatitis B

   • Jeremy S Nayagam
   • Zillah C Cargill
   • Kosh Agarwal

   Hepatitis B (JK Lim, Section Editor) Open access 28 October 2020 Pages: 362 - 369

   

6. Role of Nucleic Acid Polymers and Entry Inhibitors in Functional Cure Strategies for HBV

   • Sasan Sakiani
   • Bilal Asif
   • Christopher Koh

   Hepatitis B (JK Lim, Section Editor) 26 October 2020 Pages: 370 - 381

   

7. Alcohol Consumption in Non-Alcoholic Fatty Liver Disease: Safety and Disease Overlap

   • Sheela S. Reddy

   Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 07 September 2020 Pages: 382 - 390

   

8. Current and Emerging Treatments for Non-alcoholic Steatohepatitis

   • Christian L. Horn
   • Anvi C. Ta
   • Nadege T. Gunn

   Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 25 August 2020 Pages: 391 - 401

   

9. Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease

   • Audrey Thorp
   • Jonathan G. Stine

   Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 09 September 2020 Pages: 402 - 411

   

10. High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression

    • Yedidya Saiman
    • Royce Hooks
    • Rotonya M. Carr

    Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 01 September 2020 Pages: 412 - 419

    

11. The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease

    • Chencheng Xie
    • Dina Halegoua-DeMarzio

    Fatty Liver Disease (D Halegoua-DeMarzio, Section Editor) 02 November 2020 Pages: 420 - 428

    

12. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver Disease

    • Anita Krishnarao
    • Carmi S. Punzalan

    Fatty Liver Disease (D Halegoua-De Marzio, Section Editor) 03 November 2020 Pages: 429 - 436

    

13. LI-RADS Imaging Criteria for HCC Diagnosis and Treatment: Emerging Evidence

    • Anum Aslam
    • Richard Kinh Gian Do
    • Mishal Mendiratta-Lala

    Hepatic Cancer (N Parikh, Section Editor) 28 October 2020 Pages: 437 - 447

14. Genomic Landscape of HCC

    • Nia Adeniji
    • Renumathy Dhanasekaran

    Hepatic Cancer (N Parikh, Section Editor) 10 November 2020 Pages: 448 - 461

    

15. Racial and Sex Disparities in Hepatocellular Carcinoma in the USA

    • Faith Ajayi
    • Jenny Jan
    • Nicole E. Rich

    Hepatic Cancer (N Parikh, Section Editor) 12 November 2020 Pages: 462 - 469

16. Current Transplant Criteria for Hepatocellular Carcinoma—Overuse or Underuse

    • Varun Saxena
    • Neil Mehta

    Hepatic Cancer (N Parikh, Section Editor) 04 November 2020 Pages: 470 - 477

    

17. A Contemporary Approach to Diagnosis and Treatment of Combined Hepatocellular-Cholangiocarcinoma

    • Olga Raevskaya
    • Henry Appelman
    • Nataliya Razumilava

    Hepatic Cancer (N Parikh, Section Editor) 31 October 2020 Pages: 478 - 485

    

18. Spontaneous Bacterial Peritonitis and Secondary Bacterial Peritonitis—a Comprehensive Review

    • Gabriela Kuftinec
    • Jose Raul Estrada
    • Kalyan Ram Bhamidimarri

    Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) 06 November 2020 Pages: 486 - 498

    

19. Correction to: Hepatitis B Core Antibody: Role in Clinical Practice in 2020

    • Robert G. Gish
    • Syed Abdul Basit
    • Ulrike Protzer

    Correction Open access 07 October 2020 Pages: 499 - 499